Johnson & Johnson Share Price

Equities

JNJ

US4781601046

Pharmaceuticals

Real-time Estimate Cboe BZX 19:17:38 22/04/2024 BST 5-day change 1st Jan Change
150.2 USD +1.52% Intraday chart for Johnson & Johnson +1.68% -4.26%
Sales 2024 * 88.39B 7,155B Sales 2025 * 90.87B 7,355B Capitalization 356B 28,850B
Net income 2024 * 21.05B 1,704B Net income 2025 * 22.24B 1,800B EV / Sales 2024 * 3.95 x
Net cash position 2024 * 7B 566B Net cash position 2025 * 21.07B 1,706B EV / Sales 2025 * 3.69 x
P/E ratio 2024 *
17 x
P/E ratio 2025 *
15.9 x
Employees 131,900
Yield 2024 *
3.26%
Yield 2025 *
3.41%
Free-Float 77.1%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.51%
1 week+1.68%
Current month-5.13%
1 month-3.32%
3 months-7.63%
6 months-0.87%
Current year-4.26%
More quotes
1 week
143.13
Extreme 143.13
150.08
1 month
143.13
Extreme 143.13
159.14
Current year
143.13
Extreme 143.13
163.58
1 year
143.13
Extreme 143.13
175.97
3 years
143.13
Extreme 143.13
186.69
5 years
109.16
Extreme 109.16
186.69
10 years
81.79
Extreme 81.79
186.69
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 31/12/88
Director of Finance/CFO 57 31/12/97
Chief Tech/Sci/R&D Officer 58 04/11/19
Members of the board TitleAgeSince
Director/Board Member 70 24/04/19
Director/Board Member 72 18/06/14
Director/Board Member 70 21/10/09
More insiders
Date Price Change Volume
22/04/24 150 +1.43% 4 523 724
19/04/24 147.9 +1.49% 9,750,751
18/04/24 145.7 +0.67% 9,887,704
17/04/24 144.8 +0.22% 9,378,059
16/04/24 144.4 -2.13% 12,774,859

Delayed Quote Nyse, April 22, 2024 at 07:02 pm

More quotes
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
147.9 USD
Average target price
173.6 USD
Spread / Average Target
+17.37%
Consensus